ChAdOx1-vectored Lassa fever vaccine elicits a robust cellular and humoral immune response and protects guinea pigs against lethal Lassa virus challenge

ChAdOx1-vectored Lassa fever vaccine elicits a robust cellular and humoral immune response and protects guinea pigs against lethal Lassa virus challenge

Abstract Lassa virus (LASV) infects hundreds of thousands of individuals each year, highlighting the need for the accelerated development of preventive, diagnostic, and therapeutic interventions. To date, no vaccine has been licensed for LASV. ChAdOx1-Lassa-GPC is a chimpanzee adenovirus-vectored va...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Robert J. Fischer, Jyothi N. Purushotham, Neeltje van Doremalen, Sarah Sebastian, Kimberly Meade-White, Kathleen Cordova, Michael Letko, M. Jeremiah Matson, Friederike Feldmann, Elaine Haddock, Rachel LaCasse, Greg Saturday, Teresa Lambe, Sarah C. Gilbert, Vincent J. Munster
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Immunologic diseases. Allergy
RC581-607
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Acceso en línea:https://doaj.org/article/4667aaafa6c240a492ef4c7b8f637c7b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/4667aaafa6c240a492ef4c7b8f637c7b

Ejemplares similares